A jury has awarded $1.8 million in the first Levaquin lawsuit against Johnson & Johnson for recklessly failing to warn consumers and doctors about the risk of tendon ruptures from Levaquin. The case involved an 82-yearold man who suffered an achilles tendon rupture after taking the drug and his case was the first to be tried out of over 2,600 lawsuits around the country. Levaquin is an antibiotic approved by the FDA to stop the reproduction of bacteria. However, it has been linked to tendon ruptures, especially the achilles tendon. All of the Levaquin cases have been consolidated in Minnesota as part of multidistrict litigation.